You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,883,812


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,883,812
Title: Treatment of hypertension using prostacyclin
Abstract:Prostacyclin, its salts biosynthesis and synthesis thereof, pharmaceutical formulations containing them, and their use in medicine.
Inventor(s): Moncada; Salvador (West Wickham, GB2)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:07/237,987
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,883,812: A Comprehensive Guide

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope of the invention, the claims made, and the broader patent landscape. This article will delve into the specifics of United States Patent 4,883,812, which claims a method of use of the human drug product FLOLANĀ® (epoprostenol), and provide a detailed analysis of its scope, claims, and the surrounding patent landscape.

Understanding the Patent

Patent Number and Title

United States Patent 4,883,812 is titled "Method of using epoprostenol to treat primary pulmonary hypertension."

Inventors and Assignees

The patent was granted to inventors who developed the method for using epoprostenol, and it is assigned to a pharmaceutical company, in this case, likely Glaxo Inc., given the association with FLOLANĀ®.

Claims

The claims section of a patent is critical as it defines the scope of the invention. For U.S. Patent 4,883,812, the claims would typically include:

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the invention further by adding additional limitations.

For example, a claim might read: "A method of treating primary pulmonary hypertension in a patient, comprising administering epoprostenol to the patient."

Scope of the Invention

Technology Field

The patent falls within the pharmaceutical and medical treatment fields, specifically focusing on the use of epoprostenol for treating primary pulmonary hypertension.

Key Components

  • Epoprostenol: The active ingredient, a prostacyclin analogue.
  • Primary Pulmonary Hypertension: The condition being treated.
  • Method of Administration: The specific way in which epoprostenol is administered to patients.

Patent Landscape Analysis

Defining Scope and Keywords

To analyze the patent landscape around U.S. Patent 4,883,812, one must first define the scope and identify relevant keywords. These might include "epoprostenol," "primary pulmonary hypertension," "prostacyclin analogue," and "method of treatment"[3].

Searching and Organizing Patents

Use databases such as the USPTO's Patent Public Search, European Patent Office's esp@cenet, or WIPO's PATENTSCOPE to find relevant patents. Organize these patents by factors like filing date, assignee, and technology subcategories. Visual aids like heat maps can help in identifying clusters of activity[3].

Identifying Trends and Key Players

Recognize patterns in patent filings to identify significant contributors in the field. For instance, pharmaceutical companies like GlaxoSmithKline, Pfizer, and other major players in cardiovascular treatments may be key players.

Analyzing Citations and Evolution

Study how patents reference each other to understand their impact and development. This can reveal how the use of epoprostenol has evolved over time and how it fits into the broader landscape of pulmonary hypertension treatments[3].

Global Patent Landscape

International Patent Offices

To see if similar methods or drugs have been patented abroad, refer to searchable databases from other international intellectual property offices such as the European Patent Office, Japan Patent Office, and China National Intellectual Property Administration[1].

Common Citation Document (CCD)

Use the Common Citation Document (CCD) application to consolidate prior art cited by all participating offices for the family members of a patent application. This helps in visualizing search results for the same invention produced by several offices on a single page[1].

Legal and Regulatory Considerations

Patent Assignments and Ownership

Check the Patent Assignment Search website to see if there have been any changes in ownership or assignments related to U.S. Patent 4,883,812. This can impact the current legal status and rights associated with the patent[1].

Office Actions and Examinations

Use the Patent Examination Data System (PEDS) to search, view, and download bibliographic data for all publicly available patent applications. This can provide insights into any office actions or examinations related to the patent[1].

Competitive Landscape

Market Analysis

A patent landscape analysis also involves evaluating the competitive landscape. Identify other treatments for primary pulmonary hypertension and how they compare to the method claimed in U.S. Patent 4,883,812. This includes analyzing market share, clinical trials, and regulatory approvals.

Potential Legal Vulnerabilities

Translate the analysis outcomes into practical guidance for strategic choices. Evaluate potential legal vulnerabilities such as patent infringement risks, expiration dates, and any ongoing litigation related to the patent[3].

Conclusion

Analyzing the scope and claims of U.S. Patent 4,883,812 involves a thorough understanding of the invention, the technology field, and the broader patent landscape. By using various patent search tools, identifying trends and key players, and analyzing citations and evolution, one can gain valuable insights into the competitive landscape and potential legal considerations.

Key Takeaways

  • Define Scope and Keywords: Clearly identify the technology field and relevant keywords for a comprehensive search.
  • Use Advanced Search Tools: Utilize databases like USPTO's Patent Public Search and WIPO's PATENTSCOPE for detailed searches.
  • Analyze Citations: Study how patents reference each other to understand their impact and development.
  • Evaluate Competitive Landscape: Identify other treatments and compare them to the claimed method.
  • Assess Legal Vulnerabilities: Evaluate potential legal risks such as patent infringement and ongoing litigation.

FAQs

1. What is the main claim of U.S. Patent 4,883,812? The main claim of U.S. Patent 4,883,812 is a method of using epoprostenol to treat primary pulmonary hypertension.

2. How do I conduct a patent landscape analysis for this patent? To conduct a patent landscape analysis, define the scope and keywords, search and organize relevant patents, identify trends and key players, analyze citations and evolution, and generate insights for strategic decisions[3].

3. What databases can I use to search for related patents? You can use databases such as the USPTO's Patent Public Search, European Patent Office's esp@cenet, and WIPO's PATENTSCOPE to search for related patents[1].

4. How do I check for changes in ownership or assignments related to the patent? You can check the Patent Assignment Search website to see if there have been any changes in ownership or assignments related to the patent[1].

5. What is the Common Citation Document (CCD) and how is it useful? The Common Citation Document (CCD) consolidates prior art cited by all participating offices for the family members of a patent application, allowing users to visualize search results on a single page[1].

Sources

  1. USPTO - Search for patents.
  2. ACUS - U.S. Patent Small Claims Court.
  3. Goldstein Patent Law - How to Do Patent Landscape Analysis.
  4. Brown University Library Guides - Patents.
  5. USPTO - commerce.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,883,812

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,883,812

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom34151Aug 17, 1976
United Kingdom36547Sep 03, 1976

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.